CAPR

Capricor Therapeutics, Inc.$32.11+2.00 (+6.64%)

Prev Close$30.12·MCap$1.40B·P/E—·Vol1.05M·Yield—

▲

Buys (12M)

$0.00

▼

Sells (12M)

$5.02M

◆

Net Activity

Net Seller

$5.02M

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at Capricor Therapeutics, Inc. (CAPR) has been exclusively selling, with 0 insider purchases totaling $0.00 and 3 insider sales totaling $5.02M. The most recent insider transaction was by Sabar Karimah Es (director), who sold $3.52M worth of shares on Apr 1, 2026. Capricor Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $1.40B.

CAPR Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Apr 1, 2026	Sabar Karimah Es	director	Sell	115,000	$30.57	$3.52M	0Exit
Apr 1, 2026	Krasney Karen	officer: EVP, GENERAL COUNSEL	Sell	25,000	$30.12	$752.9K	30,547-45%
Apr 1, 2026	Bergmann Anthony	officer: CHIEF FINANCIAL OFFICER	Sell	25,000	$30.13	$753.2K	8,223-75%
Mar 3, 2025	Litvack Frank	Director	Sell	2,543	$13.67	$34.8K	0
Oct 12, 2023	Musket David B	Director	Buy	410	$2.75	$1.1K	0
Oct 10, 2023	COLLIER EARL M JR	Director	Buy	10,000	$2.83	$28.3K	0
Oct 9, 2023	Musket David B	Director	Buy	5,083	$2.82	$14.3K	0
Oct 6, 2023	Auwaerter Paul Gisbert	Director	Buy	5,000	$2.84	$14.2K	0
Oct 4, 2023	Musket David B	Director	Buy	2,500	$2.90	$7.3K	0
Aug 14, 2023	Litvack Frank	Director	Sell	4,364	$6.61	$28.8K	0
Mar 28, 2023	Avat Xavier	Insider	Sell	73,019	$4.18	$305.6K	0
Feb 21, 2023	Litvack Frank	Director	Sell	4,524	$4.31	$19.5K	0
Feb 21, 2023	Manzo Louis	Director	Sell	452	$4.31	$1.9K	0
Jun 29, 2022	Avat Xavier	CHIEF BUSINESS OFFICER	Buy	2,500	$3.73	$9.3K	0
Jun 29, 2022	Musket David B	Director	Sell	28,215	$3.77	$106.4K	0
Jun 27, 2022	Musket David B	Director	Sell	17,775	$4.44	$78.9K	0
Mar 31, 2022	Manzo Louis	Director	Sell	11,309	$3.43	$38.8K	0
Mar 29, 2022	DUNBAR GEORGE W JR	Director	Sell	6,300	$3.41	$21.5K	0
Jan 3, 2022	Litvack Frank	Director	Sell	67,552	$3.18	$214.8K	0

CAPR Insider Buying Activity

The following table shows recent insider purchases of Capricor Therapeutics, Inc. (CAPR) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value
Oct 12, 2023	Musket David B	Director	Buy	410	$2.75	$1.1K
Oct 10, 2023	COLLIER EARL M JR	Director	Buy	10,000	$2.83	$28.3K
Oct 9, 2023	Musket David B	Director	Buy	5,083	$2.82	$14.3K
Oct 6, 2023	Auwaerter Paul Gisbert	Director	Buy	5,000	$2.84	$14.2K
Oct 4, 2023	Musket David B	Director	Buy	2,500	$2.90	$7.3K
Jun 29, 2022	Avat Xavier	CHIEF BUSINESS OFFICER	Buy	2,500	$3.73	$9.3K

CAPR Insider Selling Activity

The following table shows recent insider sales of Capricor Therapeutics, Inc. (CAPR) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Apr 1, 2026	Sabar Karimah Es	director	Sell	115,000	$30.57	$3.52M	0Exit
Apr 1, 2026	Krasney Karen	officer: EVP, GENERAL COUNSEL	Sell	25,000	$30.12	$752.9K	30,547-45%
Apr 1, 2026	Bergmann Anthony	officer: CHIEF FINANCIAL OFFICER	Sell	25,000	$30.13	$753.2K	8,223-75%
Mar 3, 2025	Litvack Frank	Director	Sell	2,543	$13.67	$34.8K	0
Aug 14, 2023	Litvack Frank	Director	Sell	4,364	$6.61	$28.8K	0
Mar 28, 2023	Avat Xavier	Insider	Sell	73,019	$4.18	$305.6K	0
Feb 21, 2023	Litvack Frank	Director	Sell	4,524	$4.31	$19.5K	0
Feb 21, 2023	Manzo Louis	Director	Sell	452	$4.31	$1.9K	0
Jun 29, 2022	Musket David B	Director	Sell	28,215	$3.77	$106.4K	0
Jun 27, 2022	Musket David B	Director	Sell	17,775	$4.44	$78.9K	0
Mar 31, 2022	Manzo Louis	Director	Sell	11,309	$3.43	$38.8K	0
Mar 29, 2022	DUNBAR GEORGE W JR	Director	Sell	6,300	$3.41	$21.5K	0
Jan 3, 2022	Litvack Frank	Director	Sell	67,552	$3.18	$214.8K	0